Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1174

1.

Cutaneous Histiocytic Sarcoma With Cellular Cannibalism.

Nanri A, Katayama E, Imamura T, Muto I, Saruta H, Akiba J, Ohshima K, Nakama T, Ohata C.

Am J Dermatopathol. 2019 Sep 19. doi: 10.1097/DAD.0000000000001525. [Epub ahead of print]

PMID:
31567137
2.

Potato virus Y; the Andean connection.

Fuentes S, Jones RAC, Matsuoka H, Ohshima K, Kreuze J, Gibbs AJ.

Virus Evol. 2019 Sep 23;5(2):vez037. doi: 10.1093/ve/vez037. eCollection 2019 Jul.

3.

Driver gene alterations and activated signaling pathways toward malignant progression of gastrointestinal stromal tumors.

Ohshima K, Fujiya K, Nagashima T, Ohnami S, Hatakeyama K, Urakami K, Naruoka A, Watanabe Y, Moromizato S, Shimoda Y, Ohnami S, Serizawa M, Akiyama Y, Kusuhara M, Mochizuki T, Sugino T, Shiomi A, Tsubosa Y, Uesaka K, Terashima M, Yamaguchi K.

Cancer Sci. 2019 Sep 25. doi: 10.1111/cas.14202. [Epub ahead of print]

4.

The expression of cell adhesion molecule 1 and its splicing variants in Sézary cells and cell lines from cutaneous T-cell lymphoma.

Yamaguchi M, Morizane S, Hamada T, Miyake T, Sugaya M, Iwata H, Fujii K, Haramoto-Shiratsuki R, Nakagawa Y, Miura M, Ohshima K, Morishita K, Takahashi T, Imada M, Okada K, Uehara J, Sowa-Osako J, Iwatsuki K.

J Dermatol. 2019 Sep 12. doi: 10.1111/1346-8138.15078. [Epub ahead of print]

PMID:
31515833
5.

[Clinical features of adult-onset chronic active Epstein-Barr virus infection].

Kawamoto K, Miyoshi H, Seto M, Kimura H, Ohshima K.

Rinsho Ketsueki. 2019;60(8):944-952. doi: 10.11406/rinketsu.60.944. Japanese.

PMID:
31484894
6.

Possible biased analgesic of hydromorphone through the G protein-over β-arrestin-mediated pathway: cAMP, CellKey™, and receptor internalization analyses.

Manabe S, Miyano K, Fujii Y, Ohshima K, Yoshida Y, Nonaka M, Uzu M, Matsuoka Y, Sato T, Uezono Y, Morimatsu H.

J Pharmacol Sci. 2019 Jun;140(2):171-177. doi: 10.1016/j.jphs.2019.06.005. Epub 2019 Jul 2.

7.

Long-term eradication of extranodal NK/T cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo.

Ando M, Ando J, Yamazaki S, Ishii M, Sakiyama Y, Harada S, Honda T, Yamaguchi T, Nojima M, Ohshima K, Nakauchi H, Komatsu N.

Haematologica. 2019 Jul 11. pii: haematol.2019.223511. doi: 10.3324/haematol.2019.223511. [Epub ahead of print]

8.

[BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions].

Ogasawara T, Ebata N, Hamasaki J, Marshall S, Kawauchi K, Ohshima K, Mori N, Sakura H.

Rinsho Ketsueki. 2019;60(6):570-576. doi: 10.11406/rinketsu.60.570. Japanese.

PMID:
31281146
9.

Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma.

Natsuaki Y, Muto I, Kawamura M, Saruta H, Teye K, Ohshima K, Nakama T, Ohata C.

Am J Dermatopathol. 2019 Jun 27. doi: 10.1097/DAD.0000000000001483. [Epub ahead of print]

PMID:
31268929
10.

Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Ma G, Yasunaga JI, Ohshima K, Matsumoto T, Matsuoka M.

J Virol. 2019 Jul 30;93(16). pii: e00413-19. doi: 10.1128/JVI.00413-19. Print 2019 Aug 15.

PMID:
31167921
11.

Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.

Hatakeyama K, Nagashima T, Ohshima K, Ohnami S, Ohnami S, Shimoda Y, Serizawa M, Maruyama K, Naruoka A, Akiyama Y, Urakami K, Kusuhara M, Mochizuki T, Yamaguchi K.

Cancer Sci. 2019 Aug;110(8):2620-2628. doi: 10.1111/cas.14087. Epub 2019 Jun 24.

12.

Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Morishige S, Nishi M, Saruta H, Arakawa F, Yamasaki Y, Oya S, Nakamura T, Seki R, Yamaguchi M, Aoyama K, Mouri F, Osaki K, Ohshima K, Nagafuji K.

Int J Hematol. 2019 Oct;110(4):506-511. doi: 10.1007/s12185-019-02675-1. Epub 2019 May 31.

PMID:
31152415
13.

Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.

Kurita D, Miyoshi H, Ichikawa A, Kato K, Imaizumi Y, Seki R, Sato K, Sasaki Y, Kawamoto K, Shimono J, Yamada K, Muto R, Kizaki M, Nagafuji K, Tamaru JI, Tokuhira M, Ohshima K.

Am J Surg Pathol. 2019 Jul;43(7):869-884. doi: 10.1097/PAS.0000000000001271.

PMID:
31116708
14.

Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma.

Narazaki T, Nakashima Y, Tsukamoto Y, Tsuda M, Masuda T, Kimura D, Takamatsu A, Ohshima K, Shiratsuchi M, Ogawa Y.

Int J Hematol. 2019 Sep;110(3):375-380. doi: 10.1007/s12185-019-02656-4. Epub 2019 May 18.

PMID:
31104212
15.

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.

Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H, Zhao L, Ochi Y, Takeuchi Y, Takeda J, Ueno H, Kogure Y, Shiozawa Y, Kakiuchi N, Yoshizato T, Nakagawa MM, Nanya Y, Yoshida K, Makishima H, Sanada M, Sakata-Yanagimoto M, Chiba S, Matsuoka R, Noguchi M, Hiramoto N, Ishikawa T, Kitagawa J, Nakamura N, Tsurumi H, Miyazaki T, Kito Y, Miyano S, Shimoda K, Takeuchi K, Ohshima K, Yoshino T, Ogawa S, Kataoka K.

Leukemia. 2019 May 15. doi: 10.1038/s41375-019-0473-1. [Epub ahead of print]

PMID:
31092896
16.

[Heterogeneity of genomic alterations and clinical aspects in peripheral T-cell lymphoma: future perspectives].

Yoshida N, Seto M, Ohshima K.

Rinsho Ketsueki. 2019;60(4):271-280. doi: 10.11406/rinketsu.60.271. Japanese.

PMID:
31068555
17.

[Enteropathy-associated T-cell lymphoma coexisting with composite lymphoma composed of DLBCL and PTCL].

Imanishi D, Hata T, Imaizumi Y, Niino D, Ohshima K, Miyazaki Y.

Rinsho Ketsueki. 2019;60(3):197-202. doi: 10.11406/rinketsu.60.197. Japanese.

PMID:
31068515
18.

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement.

Kato T, Itonaga H, Taguchi J, Makiyama J, Fujioka M, Taguchi M, Horai M, Sawayama Y, Niino D, Imaizumi Y, Hata T, Yoshida S, Sakamoto K, Takeuchi K, Ohshima K, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:31-33. doi: 10.1016/j.lrr.2019.04.005. eCollection 2019.

19.

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.

Sakamoto H, Itonaga H, Taguchi J, Kato T, Sawayama Y, Hayashi T, Baba S, Moriuchi M, Ohshima K, Yoshida S, Moriuchi Y, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:27-30. doi: 10.1016/j.lrr.2019.04.003. eCollection 2019.

20.

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Kawano N, Yoshida N, Kawano S, Arakawa F, Miyoshi H, Yamada K, Nakashima K, Yoshida S, Kuriyama T, Tochigi T, Nakaike T, Shimokawa T, Yamashita K, Marutsuka K, Mashiba K, Kikuchi I, Ohshima K.

Intern Med. 2019 Aug 1;58(15):2159-2166. doi: 10.2169/internalmedicine.2513-18. Epub 2019 Apr 17.

21.

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.

Komaki S, Sugita Y, Furuta T, Yamada K, Moritsubo M, Abe H, Akiba J, Miyagi N, Nakamura H, Miyoshi H, Ohshima K, Morioka M.

J Neuropathol Exp Neurol. 2019 May 1;78(5):389-397. doi: 10.1093/jnen/nly124.

22.

Integrated datasets of normalized brain with functional localization using intra-operative electrical stimulation.

Tamura M, Sato I, Maruyama T, Ohshima K, Mangin JF, Nitta M, Saito T, Yamada H, Minami S, Masamune K, Kawamata T, Iseki H, Muragaki Y.

Int J Comput Assist Radiol Surg. 2019 Apr 6. doi: 10.1007/s11548-019-01957-7. [Epub ahead of print]

PMID:
30955195
23.

Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.

Satou A, Tabata T, Miyoshi H, Kohno K, Suzuki Y, Yamashita D, Shimada K, Kawasaki T, Sato Y, Yoshino T, Ohshima K, Takahara T, Tsuzuki T, Nakamura S.

Mod Pathol. 2019 Jul;32(8):1135-1146. doi: 10.1038/s41379-019-0264-2. Epub 2019 Apr 5.

PMID:
30952973
24.

Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.

Kamachi K, Kubota Y, Nagaie T, Yamaguchi K, Ogusu S, Kidoguchi K, Kusaba K, Kizuka-Sano H, Nishioka A, Yoshimura M, Yokoo M, Ando T, Kai K, Kojima K, Ohshima K, Sueoka E, Kimura S.

Intern Med. 2019 Jul 15;58(14):2073-2077. doi: 10.2169/internalmedicine.2532-18. Epub 2019 Mar 28.

25.

Anaplastic large cell lymphoma, with 1,25(OH)2D3-mediated hypercalcemia: A case report.

Mitobe M, Kawamoto K, Suzuki T, Kiryu M, Nanba A, Suwabe T, Tanaka T, Fuse K, Shibasaki Y, Masuko M, Miyoshi H, Ohshima K, Sone H, Takizawa J.

J Clin Exp Hematop. 2019;59(1):22-28. doi: 10.3960/jslrt.18033.

26.

Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy.

Tanaka Y, Ishihara M, Miyoshi H, Hashimoto A, Shinzato I, Ohshima K.

J Clin Exp Hematop. 2019;59(1):17-21. doi: 10.3960/jslrt.18020.

27.

Serum deprivation-response protein regulates aldehyde dehydrogenase 1 through integrin-linked kinase signaling in endometrioid carcinoma cells.

Tahara S, Nojima S, Ohshima K, Hori Y, Kurashige M, Wada N, Motoyama Y, Okuzaki D, Ikeda JI, Morii E.

Cancer Sci. 2019 May;110(5):1804-1813. doi: 10.1111/cas.14007. Epub 2019 Apr 11.

28.

Pepper veinal mottle virus in Japan is closely related to isolates from other Asian countries, but more distantly to most of those from Africa.

Laina JA, Matsumoto K, Setoyama T, Kawano S, Ohshima K.

Virus Genes. 2019 Jun;55(3):347-355. doi: 10.1007/s11262-019-01656-0. Epub 2019 Mar 20.

PMID:
30895438
29.

Identification of a neoantigen epitope in a melanoma patient with good response to anti-PD-1 antibody therapy.

Nonomura C, Otsuka M, Kondou R, Iizuka A, Miyata H, Ashizawa T, Sakura N, Yoshikawa S, Kiyohara Y, Ohshima K, Urakami K, Nagashima T, Ohnami S, Kusuhara M, Mitsuya K, Hayashi N, Nakasu Y, Mochizuki T, Yamaguchi K, Akiyama Y.

Immunol Lett. 2019 Apr;208:52-59. doi: 10.1016/j.imlet.2019.02.004. Epub 2019 Mar 14.

30.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.

PMID:
30782609
31.

A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.

Iizuka A, Nonomura C, Ashizawa T, Kondou R, Ohshima K, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Akiyama Y.

Clin Cancer Res. 2019 May 1;25(9):2925-2934. doi: 10.1158/1078-0432.CCR-17-3123. Epub 2019 Feb 8.

PMID:
30737243
32.

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Shimono J, Miyoshi H, Arakawa F, Yamada K, Sugio T, Miyawaki K, Eto T, Miyagishima T, Kato K, Nagafuji K, Akashi K, Teshima T, Ohshima K.

Ann Hematol. 2019 May;98(5):1197-1207. doi: 10.1007/s00277-019-03628-8. Epub 2019 Feb 7.

PMID:
30729289
33.

Identification of a novel CCDC22 mutation in a patient with severe Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis and aggressive natural killer cell leukemia.

Yamashita Y, Nishikawa A, Iwahashi Y, Fujimoto M, Sasaki I, Mishima H, Kinoshita A, Hemmi H, Kanazawa N, Ohshima K, Imadome KI, Murata SI, Yoshiura KI, Kaisho T, Sonoki T, Tamura S.

Int J Hematol. 2019 Jun;109(6):744-750. doi: 10.1007/s12185-019-02595-0. Epub 2019 Jan 31.

PMID:
30706328
34.

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):544. doi: 10.1038/s41564-019-0387-8.

PMID:
30705423
35.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jul;33(7):1687-1699. doi: 10.1038/s41375-019-0380-5. Epub 2019 Jan 25.

36.

Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Erratum in: Nat Microbiol. 2019 Jan 30;:.

PMID:
30664667
37.

Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma.

Takeuchi M, Miyoshi H, Asano N, Yoshida N, Yamada K, Yanagida E, Moritsubo M, Nakata M, Umeno T, Suzuki T, Komaki S, Muta H, Furuta T, Seto M, Ohshima K.

Haematologica. 2019 Aug;104(8):1626-1632. doi: 10.3324/haematol.2018.205567. Epub 2019 Jan 10.

38.

Is clinicopathological distinction of mucosa-associated lymphoid tissue lymphoma from Waldenström macroglobulinemia essential in MYD88 L265P mutation-positive cases?

Kidoguchi K, Kojima K, Seki R, Nagafuji K, Ohshima K, Kimura S.

Int J Hematol. 2019 Mar;109(3):247-248. doi: 10.1007/s12185-018-02585-8. Epub 2019 Jan 3. No abstract available.

PMID:
30604315
39.

Malignant progression of an extraventricular neurocytoma arising from the VIIIth cranial nerve: A case report and literature review.

Sugita Y, Furuta T, Komaki S, Ohshima K, Sakata K, Morioka M.

Neuropathology. 2019 Apr;39(2):120-126. doi: 10.1111/neup.12533. Epub 2018 Dec 26. Review.

PMID:
30588667
40.

Complete Genome Sequences of Seven Peanut Stunt Virus Strains from Japan.

Takahashi H, Ogawa A, Inoue S, Yasaka R, Ohshima K, Ugaki M, Suzuki M.

Microbiol Resour Announc. 2018 Sep 27;7(12). pii: e00952-18. doi: 10.1128/MRA.00952-18. eCollection 2018 Sep.

41.

An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma.

Muto R, Sugita Y, Momosaki S, Ito Y, Wakugawa Y, Ohshima K.

Neuropathology. 2019 Feb;39(1):58-63. doi: 10.1111/neup.12526. Epub 2018 Dec 3.

PMID:
30511425
42.

Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer.

Ohshima K, Hatakeyama K, Kanto K, Ide T, Watanabe Y, Moromizato S, Wakabayashi-Nakao K, Sakura N, Yamaguchi K, Mochizuki T.

Oncol Rep. 2019 Feb;41(2):1019-1034. doi: 10.3892/or.2018.6869. Epub 2018 Nov 15.

PMID:
30431134
43.

Locally distributed multicentric plasmacytomas in the ileum secondary to lymphoma chemoimmunotherapy.

Yokoo M, Kojima K, Sano H, Kai K, Arakawa F, Ohshima K, Matsunaga T, Kimura S.

Ann Hematol. 2019 Jun;98(6):1501-1503. doi: 10.1007/s00277-018-3543-y. Epub 2018 Nov 8. No abstract available.

PMID:
30406822
44.

Safety and effective salvage regimen comprising a novel combination of brentuximab vedotin, L-asparaginase, and dexamethasone for refractory anaplastic large cell lymphoma, anaplastic lymphoma kinase negative.

Kawamoto K, Suzuki T, Kasami T, Kiryu M, Sone H, Miyoshi H, Ohshima K, Takizawa J.

Hematol Oncol. 2019 Apr;37(2):212-214. doi: 10.1002/hon.2565. Epub 2018 Nov 19. No abstract available.

PMID:
30394560
45.

Classification of tumor microenvironment immune types based on immune response-associated gene expression.

Kondou R, Iizuka A, Nonomura C, Miyata H, Ashizawa T, Nagashima T, Ohshima K, Urakami K, Kusuhara M, Yamaguchi K, Akiyama Y.

Int J Oncol. 2019 Jan;54(1):219-228. doi: 10.3892/ijo.2018.4617. Epub 2018 Nov 2.

PMID:
30387832
46.

Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical Studies.

Miyano K, Nonaka M, Uzu M, Ohshima K, Uezono Y.

Front Nutr. 2018 Oct 8;5:93. doi: 10.3389/fnut.2018.00093. eCollection 2018. Review.

47.

Modification of cellular and humoral immunity by somatically reverted T cells in X-linked lymphoproliferative syndrome type 1.

Hoshino A, Yang X, Tanita K, Yoshida K, Ono T, Nishida N, Okuno Y, Kanzaki T, Goi K, Fujino H, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H.

J Allergy Clin Immunol. 2019 Jan;143(1):421-424.e11. doi: 10.1016/j.jaci.2018.07.044. Epub 2018 Oct 17. No abstract available.

PMID:
30342818
48.

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Muto R, Miyoshi H, Sato K, Furuta T, Muta H, Kawamoto K, Yanagida E, Yamada K, Ohshima K.

Cancer Med. 2018 Nov;7(11):5843-5858. doi: 10.1002/cam4.1805. Epub 2018 Oct 11.

49.

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.

Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Am J Surg Pathol. 2018 Nov;42(11):1466-1471. doi: 10.1097/PAS.0000000000000969.

50.

Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy.

Matsukawa T, Suto K, Miyoshi H, Oshimi K, Ohshima K, Miyagishima T.

J Clin Exp Hematop. 2018 Dec 13;58(4):184-187. doi: 10.3960/jslrt.18027. Epub 2018 Oct 10. No abstract available.

Supplemental Content

Loading ...
Support Center